Skip to content
Governance Register

← US public companies

Orbimed Genesis GP LLC

SEC-identified person · CIK 1808744 Identifier-verified

Public-company roles (from insider filings)

CompanyCapacity as filedFilings
Imara Inc. IMRA Director filed 2023–2026
Shattuck Labs, Inc. STTK Director filed 2025–2026
Q32 Bio Inc. QTTB Director filed 2026–2026
Prelude Therapeutics Inc PRLD Director filed 2026–2026
Imagenebio, Inc. IMA Director filed 2021–2026
Restorbio, Inc. TORC Director filed 2021–2026
Keros Therapeutics, Inc. KROS Director filed 2020–2025
Olivia Ventures, Inc. CMPX Director filed 2021–2025
Edgewise Therapeutics, Inc. EWTX Director filed 2021–2025
Gemini Therapeutics, Inc. /DE IRON Director filed 2023–2025
MBX Biosciences, Inc. MBX Director filed 2024–2025
Scpharmaceuticals Inc. SCPH Officer filed 2020–2024
Terns Pharmaceuticals, Inc. TERN Director filed 2022–2024
Nivalis Therapeutics, Inc. NVLS Director filed 2021–2024
Kinnate Biopharma Inc. KNTE Director filed 2020–2024
Theseus Pharmaceuticals, Inc. THRX Director filed 2021–2024
PMV Pharmaceuticals, Inc. PMVP Director filed 2020–2023
Galecto, Inc. GLTO Director filed 2020–2023
Sierra Oncology, Inc. SRRA Director filed 2022–2022
Janux Therapeutics, Inc. JANX Director filed 2021–2021
Decibel Therapeutics, Inc. [DBTX] Director filed 2021–2021
Logicbio Therapeutics, Inc. LOGC Director filed 2020–2020
Pandion Therapeutics, Inc. PAND Officer filed 2020–2020

All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.